Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: Results from the Korean National Health and Nutrition Examination Survey

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 469-477

  Yu, Mina ^a   Ryu, Dong Ryeol ^a   Kim, Seung Jung ^a   Choi, Kyu Bok ^a   Kang, Duk Hee ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Chronic kidney disease; Gender difference; Metabolic syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; METABOLIC SYNDROME X; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOUTH KOREA;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MENOPAUSE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; YOUNG ADULT;

EID: 75649117808     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp483     Document Type: Article

References (46)

1. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from kidney disease improving global outcomes. Kidney Int 2007; 72: 247-259
2. Coresh J, Byrd-Holt D, Astor BC et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16: 180-188
3. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444-2449
4. Nestel P, Lyu R, Low LP et al. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 2007; 16: 362-367
5. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 7: 2038-2047 (Pubitemid 350074801)
6. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174
7. Tanaka H, Shiohira Y, Uezu Y et al. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006; 69: 369-374
8. Chen J, Gu D, Chen CS et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 2007; 22: 1100-1106
9. Chen CH, Lin KC, Tsai ST et al. Different association of hypertension and insulin-related metabolic syndrome between men and women in 8437 nondiabetic Chinese. Am J Hypertens 2000; 13: 846-853
10. Halbesma N, Brantsma AH, Bakker SJ et al. Gender differences in predictors of the decline of renal function in the general population. Kidney Int 2008; 74: 505-512
11. Kim HM, Park J, Ryu SY et al. The effect of menopause on the metabolic syndrome among Korean Women. Diabetes Care 2007; 30: 701-706
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
13. Levey AS, Bosch JP, Lewis JB et al. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
14. Fox CS, Larson MG, Keyes MJ et al. Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: the Framingham Heart study Kidney Int 2004; 66: 2017-2021
15. Coresh J, Astor BC, McQuillan G et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 5: 20-29
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497
17. World Health Organization/International Association for the Study of Obesity/International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Available at: www.iotf. org/asiapacific. [Date last accessed 11 July 2006].
18. National-Kidney-Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-S266
19. The Expert Committeeon the Diagnosis and Classification of Diabete. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197
20. Kereiakes DJ, Willerson JT. Metabolic syndrome epidemic. Circulation 2003; 108: 1552-1553
21. Eknoyan G, Lameire N, Barsoum R et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004; 66: 1310-1314
22. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140
23. Ninomiya T, Kiyohara Y, Kubo M et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama study. Am J Kidney Dis 2006; 48: 383-391
24. Luk AO, So WY, Ma RC et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 2008; 31: 2357-2361
25. Tozawa M, Iseki C, Tokashiki K et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 2007; 30: 937-943
26. Rashidi A, Ghanbarian A, Azizi F. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol 2007; 2: 976-983
27. Kitiyakara C, Yamwong S, Cheepudomwit S et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 2007; 71: 693-700
28. Tan CE, Ma S, Wai D et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186
29. Gu D, Reynolds K, Wu X et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405
30. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome amongUSadultsfindings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359
31. Balkau B, Charles MA, Drivsholm T et al. Frequency of the WHO metabolic syndrome in European cohorts, andan alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-376
32. Kraja AT, Rao DC, Weder AB et al. An evaluation of the metabolic syndrome in a large multi-ethnic study: the Family Blood Pressure Program. Nutr Metab (Lond) 2005; 2:17
33. Domrongkitchaiporn S, Sritara P, Kitiyakara C et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 2005; 16: 791-799
34. Kim SM, Han JH, Park HS. Prevalence of low HDL-cholesterol levels and associated factors among Koreans. Circ J 2006; 70: 820-826
35. Ko M, Kim MT, Nam JJ. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. Int J Cardiol 2006; 110: 184-190
36. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88: 2404-2411
37. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007; 4(Suppl B): S162-S177
38. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716
39. US Renal Data System (USRDS) 2007 Annual Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2007
40. Soni SS, Gowrishankar S, Adikey GK et al. Sex-based differences in lupus nephritis: a study of 2365 Indian patients. J Nephrol 2008; 21: 570-575
41. Silbiger SR, Neugarten N. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 1995; 25: 515-533
42. Zhang X, Jia Y, Jackson EK et al. 2-Methoxyestradiol and 2-ethoxyestradiol retard the progression of renal disease in aged, obese, diabetic ZSF1 rats. J Cardiovasc Pharmacol 2007; 49: 56-63
43. Tozawa M, Iseki C, Tokashiki K et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 2007; 30: 937-943
44. Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol 2006; 164: 263-271
45. Stengel B, Couchoud C, Cénée S et al. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 2000; 57: 2519-2526
46. Ejerblad E, Fored CM, Lindblad P et al. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 2004; 15: 2178-2185